Injective (INJ) is currently priced at $2.89, reflecting a minor increase of 0.42% over the last 24 hours. The daily trading range has been tight, with a high of $2.91 and a low of $2.84, indicating low volatility in the current market environment.

Trading volume over the past 24 hours stands at approximately 44.65 million, translating to a volume-to-market cap ratio of 15.45%. This relatively healthy volume suggests consistent trading interest, although it remains below the levels typically seen during bullish phases.

Analyzing the hourly moving averages reveals mixed signals; the 8 SMA and 13 SMA are showing upward momentum, while the 55 SMA indicates a decline. Notably, the 144 SMA is significantly below the current price, reflecting a longer-term bearish trend, which could indicate resistance at higher levels around $2.99.

The 1-hour RSI is at 57, suggesting that the asset is nearing overbought conditions, while the 7-day RSI is at 48, indicating neutral momentum. However, the 7-day and 14-day price changes are both negative, with declines of approximately 6.65% and 4.36%, respectively, highlighting a short-term bearish sentiment that has persisted over the last month.

Injective's all-time high of $52.62, reached in March 2024, remains significantly above the current price, suggesting substantial downside from historical peaks. The persistent downward trend over the past 30 days, with a decline of nearly 9.90%, reinforces the bearish outlook for short-term trading opportunities.

Given the current technical indicators, with short-term moving averages supporting a slight upward trend but longer-term averages and price changes suggesting a bearish sentiment, I recommend a Hold rating. Investors should wait for clearer bullish signals or a breakout above the $2.99 resistance before considering new positions or adding to existing ones.